Breaking Monster Wildfire Forces Mass Evacuations in Southwest France Haitian TPS Holders in South Florida Face Uncertainty After Supreme Court Ruling FCC Bans Import of Foreign-Made Humanoid Robots Amid Security Concerns Nevada Judge Rules 2008 Police Interview Admissible in Tupac Shakur Murder Trial Jordan Intercepts Iranian Missiles; U.S. Reports All Missiles Stopped, Strikes on Militias

Wednesday July 29, 2026

Reporter

InnoCare Pharma

4Articles Published

4Communities Covered

Published Articles

Press Release

InnoCare Announces Phase II Study Results of TYK2 Inhibitor Soficitinib Meet Primary Endpoint in Patients with Vitiligo

Jul 16

Press Release

InnoCare Announces Phase III Study Results of TYK2 Inhibitor Soficitinib Meet Primary Endpoint in Patients with Atomic Dermatitis

Jul 15

Press Release

InnoCare Announces Publication in STTT (IF=81.2) of Phase 3 Results Showing Orelabrutinib Significantly Prolonged Progression-Free Survival in Treatment-Naïve CLL/SLL

Jul 14

Press Release

Study Results of Orelabrutinib in Patients with SLE Published in the Journal of Autoimmunity

Jul 10